RACHEL RODAL: Open Payments
NPI 1881252666 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,837 in 127 payments from 13 companies in 2025. Trend: 2023 $1,923 · 2024 $1,821 · 2025 $2,837
Food & beverage: $2,638Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $794 |
| ABBVIE INC. | 42 | $730 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $343 |
| Madrigal Pharmaceuticals | 4 | $242 |
| Ardelyx, Inc. | 10 | $196 |
| Phathom Pharmaceuticals, Inc. | 11 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $84 |
| GENZYME CORPORATION | 3 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $45 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, ENTYVIO, IBSRELA, LINZESS, SKYRIZI, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
